News Archives

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

Select Year: 2009 : 2008
11.16.2009 AUSTIN-BASED BIOTECH COMPANY’S VACCINE RESEARCH TO CONTINUE ON ATLANTIS MISSION

For the fourth time this year, NASA’s Shuttle fleet is carrying a series of experiments being conducted by Austin-based Astrogenetix, a commercial biotech company created to use microgravity to develop the foundation of new medicines....
> Read More

08.25.2009 SPACE SHUTTLE DISCOVERY TO CARRY VACCINE RESEARCH ALONG WITH INTERNATIONAL SPACE STATION EQUIPMENT

Astrogenetix Works with NASA to Use Microgravity to Develop New Medicines

Along with supply and equipment cargo bound for the International Space Station, Space Shuttle Discovery STS-128 will carry an additional scientific payload being conducted by Austin-based Astrogenetix, the first commercial space company to use microgravity to discover the foundation of new medicines....
> Read More

07.20.2009 ASTROTECH STATEMENT ON THE 40TH ANNIVERSARY OF APOLLO 11 MOON LANDING

Astrotech Corporation (NASDAQ: ASTC) Chairman and Chief Executive Officer, Thomas B. Pickens III today issued the following statement regarding the 40th anniversary of the first moon landing by Apollo 11....
> Read More

05.14.2009 ASTROGENETIX ADVANCES MRSA RESEARCH ON HUBBLE FLIGHT

Astrogenetix, Inc., a subsidiary of the Astrotech Corporation (Nasdaq:ASTC), today announced preliminary findings from its microgravity-based virulence survey aboard Shuttle Discovery (STS-119) launched on March 15, 2009. These results showed that methicillin-resistant Staphylococcus aureus (MRSA) and other microbes exhibit altered phenotypical responses during spaceflight....
> Read More

03.11.2009 ASTROGENETIX TO CONDUCT MRSA RESEARCH ON SHUTTLE MISSION

Astrogenetix, Inc., a subsidiary of the Astrotech Corporation, today announced it is conducting novel pharmaceutical research aboard Shuttle Discovery (STS-119) on NASA mission 15A scheduled to launch this evening and destined for the International Space Station (ISS)....
> Read More